Rectal Tumor clinical trials at UC Irvine

1 research study open to eligible people

CG-100 Intraluminal Bypass Device
open to eligible people ages 22-70
A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.
Orange 5379513, California 5332921 and other locations

Last updated: October 21, 2025